脑溢安颗粒对脑出血大鼠脑组织bcl-2表达的影响

目的 :探讨脑溢安颗粒 (简称脑溢安 )治疗脑出血的疗效机制。方法 :立体定位于苍白球内注射Ⅶ型胶原酶诱导大鼠脑出血模型 ,采用免疫组织化学法检测脑溢安组与各对照组脑组织内bcl 2蛋白表达。结果 :模型组脑组织内bcl 2阳性细胞在 1d开始增加 ,2d达峰值 ,7d时明显减少 ;脑溢安组其bcl 2阳性细胞在 2d ,4d ,7d明显高于模型组。结论 :脑溢安可上调bcl 2表达     

脑溢安颗粒对脑出血大鼠脑组织bcl—2表达的影响

目的：探讨脑安颗粒（简称脑溢安）治疗脑出血的疗效机制。方法：立体定位于苍白球内注射Ⅶ型胶原酶诱导大鼠脑出血模型，舸用免疫组织化学法检测脑溢安组与各对照组脑组织内bcl-2蛋白表达。结果：模型组脑组织内bcl-2阳性细胞在1d开始增加，2d达峰值，7d时明显减少；脑溢安组其bcl-2阳性细胞在2d，4d，7d明显高于模型组。结论：脑溢安可上调bcl-2表达。     

脑溢安对脑出血大鼠脑内含铁血红素氧合酶-1的影响

目的 :探讨脑溢安对脑出血后含铁血红素氧合酶 1(hemeoxygenase 1,HO 1)表达的影响。方法 :采用胶原酶复制大鼠脑出血模型 ,以免疫组化法观察脑出血后脑内HO 1的表达情况 ,计数HO 1的阳性细胞。结果 :脑出血后 ,模型组大鼠脑内HO 1第 12h即有表达 ,第 2d达高峰 ,第 7d仍有表达 ;而脑溢安在第 2 4h即明显增强大鼠脑内HO 1表达。结论 :脑出血后 ,脑内HO 1表达增加 ;脑溢安可能通过上调HO 1的表达 ,实现其神经元保护作用     

脑溢安对脑出血大鼠脑源性神经营养因子蛋白表达的影响

目的 :观察脑出血模型大鼠脑内脑源性神经营养因子 (BDNF)的分布以及中药脑溢安对其影响。方法 :通过微量注射器向苍白球内注入Ⅶ型胶原酶 0 .4U建立脑出血模型 ,用免疫组织化学法观察脑出血后 2h ,6h ,12h ,1d ,4d ,7d ,6个时间点BDNF的表达变化 ,以阳性细胞计数作为观察指标。结果 :脑出血后 2h ,BDNF主要表达于血肿周围的小胶质细胞 ,6h表达开始增高 ,12h后达高峰 ,以后逐渐降低 ,到第 7天模型组和脑溢安组仍有表达 ,其中在 12h ,1d ,4d ,3个时间点上 ,两组阳性细胞计数比较差异有显著性 (P <0 .0 5 )。结论 :脑溢安可促进脑出血后BDNF蛋白的表达     

脑溢安对脑出血大鼠脑内含铁血红素氧合酶—1的影响

目的：探讨脑溢安对脑血血后含铁血红素氧保酶－1(heme oxygenase-1,HO-1）表达的影响。方法：采用胶原酶复制大鼠脑出血模型，以免疫组化法观察脑出血后脑内HO－1的表达情况，计数HO－1的阳性细胞。结果：脑出血后，模型组大鼠脑内HO－1第12h即有表达，第2d达高峰，第7d仍有表达；脑溢安在第24h即明显增强大鼠脑内HO－1表达。结论：脑出血后，脑内HO－1表达增加；脑溢安可能通过上调HO－1的表达，实现其神经元保护作用。     

脑溢安颗粒对脑出血大鼠脑内IL-6表达的影响

目的 :研究脑出血大鼠脑内IL 6表达的细胞定位及脑溢安颗粒 (简称脑溢安 )对IL 6表达的影响 ,探讨脑溢安治疗脑出血的作用机制。方法 :采用胶原酶注射建立大鼠脑出血模型 ,以免疫组织化学方法检测脑出血后大鼠脑内白介素 6 (interleukin 6 ,IL 6 )的蛋白表达及胶质细胞反应。结果 :脑出血后 6h～ 4d血肿区域可以检测到小胶质细胞活性 ,6h～ 7d血肿外周可以见到星形胶质细胞反应 ;脑出血后 6h血肿区域即有IL 6表达 ,于 12h达高峰 ,7d时消失。结论 :脑出血后大鼠脑内IL 6阳性细胞主要为血肿区域的神经元和激活的小胶质细胞 ,脑溢安可能通过维持IL 6的上增性表达在脑出血损伤中发挥神经保护和神经营养作用     

实验性脑出血大鼠脑组织Bcl-2,Bax蛋白表达特点及中药干预

目的 :从Bcl 2 ,Bax蛋白表达的时相、部位、量的变化特点 ,探讨其与脑出血损伤之间的关系及中药脑溢安对出血损伤脑组织的保护作用机制。方法 :Rosenberg方法复制大鼠脑出血模型 ,采用免疫组化法检测脑溢安组与各对照组在损伤的不同时相与病理分区中Bcl 2 ,Bax的阳性细胞 ,观察分析两种阳性细胞的变化特征。结果 :出血区可见Bax的表达 ,其阳性神经元形态变化较大 ,损伤较重 ;缺血反应区可见Bcl 2表达 ,其阳性神经元形态正常 ;出血边缘区可见Bax及Bcl 2的表达 ,在 2d ,4d ,7d脑溢安组与模型组比较Bcl 2表达增强 (均P <0 .0 1 ) ;在 1 2h ,1d ,2d ,4d ,7dBax表达降低 (均P <0 .0 1 )。结论 :大鼠脑出血后Bcl 2 ,Bax表达与脑组织损伤程度、时相、部位有关 ;脑溢安能上调Bcl 2表达及下调Bax表达     

脑溢安干预大鼠脑出血对丝氨酸/苏氨酸激酶表达影响的研究

目的：观察脑出血后丝氨酸／苏氨酸（Serine/threonine Kinase Akt)的表达及中药制剂脑溢安的干预作用。方法：用Ⅶ型胶原酶于脑内定位注射诱导大鼠脑出血模型，用免疫组织化学法观测脑内有Akt表达的阳性神经元细胞与数目。结果：大鼠脑出血后12h时Akt开始表达增加，4d时Akt达到高峰，7d时仍有表达均高于假手术组（P＜0．01），脑溢安治疗组在脑出血后24h,2d,4d,7d各时间占Akt的表达均较模型组明显增高（P＜0．05），结论：大鼠脑出血后Akt表达增加，脑溢安对Akt有上调作用。     

脑溢安对脑出血大鼠脑内GDNF蛋白及mRNA表达的影响

目的观察脑出血模型大鼠脑内胶质细胞源性神经营养因子（GDNF）蛋白和mRNA的分布及中药脑溢安对其影响。方法通过微量注射器向苍白球注入Ⅶ型胶原酶0．4u建立脑出血模型。用免疫组织化学方法和原住杂交法分别观察脑出血后2h，6h，1d，4d，7d，14d共6个时间点GDNF蛋白及mRNA的表达变化，以阳性细胞计数作为观察指标。结果脑出血后2hGDNF蛋白主要表达于血肿周围的星型胶质细胞，6h表达开始增高，1d达高峰，以后逐渐降低，GDNF蛋白到第7天基本恢复到正常水平，14d后GDNF阳性细胞消失；在1d，4d两个时间点上，两组阳性细胞计数比较差异有显著性（P〈0．05）；而GDNF mRNA主要表达于神经元，1d后达高峰，7d后两者的表达水平继续下降但仍高于正常，14d后降至基础水平，在6h，1d，4d三个时间点上，两组阳性细胞计数比较差异有显著性（P〈0．01）。结论脑溢安可促进脑出血后GDNF蛋白及mRNA的表达。     

脑溢安颗粒对脑出血大鼠脑内IL—6表达的影响

目的：研究脑出血大鼠脑内IL－6表达的细胞定位及脑溢安颗粒（简称脑溢安）对IL－6表达的影响，探讨脑溢安治疗脑出血的作用机制。方法：采用胶原酶注射建立大鼠脑出血模型，以免疫组织化学方法检测脑出血后大鼠脑内白介素6（interleukin-6,IL-6)的蛋白表达及胶质细胞反应。结果：脑出血后6h-4d血肿区域可以检测到小胶质细胞活性，6h-7d血肿外周可以见到星形胶质细胞反应；脑出血后6h血肿区域即有IL－6表达，于72h达高峰，7d时消失。结论：脑出血后大鼠脑内IL－6阳性细胞主要为血肿区域的神经元和激活的小胶质细胞，脑溢安可能通过维持IL－6的上增性表达在脑出血损伤中发挥神经保护和神经营养作用。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…